DECEMBER 2016

Back at the lab after 2 days of lab retreat. We are very thankful to our guests Dr. Tolosa, Dr. Raya, Dr. Vila and Dr. Juan for their valuable suggestions and discussion. Looking forward to starting the new projects and collaborations!

NOVEMBER 2019

Congratulations to Alba Tristán for completing her PhD, titled: Tyrosine hydroxylase Deficiency: Studies in patient samples and in a cellular model.

OCTOBER 2019

We participated in the ESGCT-SETGyC collaborative congress that was held in Barcelona. Our post-doc and PhD Students presented their results in patient-specific iPSC-derived astrocytes, microglia and ventral midbrain organoids.

SEPTEMBER 2019

You can access our most recent paper titled: Enhancing glycolysis attenuates Parkinson’s disease progression in models and clinical databases that has been published in The Journal of Clinical Investigation here: https://www.jci.org/articles/view/129987

 

AUGUST 2019

Congratulations to Giulia Carola for completing her PhD, titled: “Investigating Early Functional Alteration in a Human iPSC-Based Model of Parkinson Disease”.

JULY 2019

Our research article “Patient-Specific iPSC-Derived Astrocytes Contribute to Non-Cell-Autonomous Neurodegeneration in Parkinson’s Disease“, has been selected by the prestigious Stem Cell Reports magazine to be part of its annual “Best of” compilation. The study has been selected based on the number of downloads by readers, a criterion that publishers consider the most impartial way to evaluate the interest in a specific work.

JULY 2019

We participated in the XIV European Meeting on Glial Cells in Health and Disease that was held in Porto, Portugal. Lucas and Meritxell presented their results in patient-specific iPSC-derived microglia and astrocytes.

JUNE 2019

On June 5, the Department of Pathology and Experimental Therapy of the Faculty of Medicine and Health Science from the UB organized their first Research Meeting. As a part of the department, we participated with a poster explaining our work modeling Parkinson’s Disease using iPS cell technology.